Skip to main content

Table 7 Discrete choice model of association between GI events and receipt of bisphosphonate treatment (versus non-bisphosphonate)a

From: Association between gastrointestinal events and osteoporosis treatment initiation in women diagnosed with osteoporosis in France: a retrospective analysis

Effect Estimated odds ratio 95 % CI p value
Pre-index GI event (ref: no pre-index GI event) 0.846 (0.74, 0.95) 0.0009
Post-index GI event (ref: no post-index GI event) 0.654 (0.57, 0.74) <0.0001
Age group    
 65–74 vs. 55–64 0.962 (0.87, 1.06) 0.0613
 75–84 vs. 55–64 0.785 (0.71, 0.87) 0.0023
 85+ vs. 55–64 0.720 (0.54, 0.97) 0.0624
Pre-index Medication Use    
 Gastro-protective agents 0.684 (0.62, 0.76) <0.0001
 NSAIDs 1.066 (0.97, 1.17) 0.1835
 Glucocorticoids 0.982 (0.88, 1.09) 0.7334
Charlson comorbidity index score 0.961 (0.92, 1.01) 0.0963
  1. NSAIDs non-steroidal anti-inflammatory drugs
  2. aAmong patients who initiated treatment
  3. CI confidence interval